Centaurus Financial, Inc. Senseonics Holdings, Inc. Transaction History

Centaurus Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.97 - $1.94 $16,166 - $32,333	-16,667 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$1.81 - $2.45 $30,093 - $40,733	16,626 Added 40551.22%	16,667 $34,000
Q1 2019 Jul 01, 2019	SELL	$2.3 - $3.27 $38,239 - $54,367	-16,626 Reduced 99.75%	41 $16.7 Million
Q1 2019 May 13, 2019	BUY	$2.3 - $3.27 $38,334 - $54,501	16,667 New	16,667 $41,000
Q3 2018 Nov 05, 2018	SELL	$3.4 - $4.84 $5,667 - $8,068	-1,667 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$3.03 - $4.98 $5,051 - $8,301	1,667 New	1,667 $7,000

138

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $410M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.